Ovid Therapeutics Inc. reports $1.3 billion Q1 loss
The company generated $66.20 million in quarterly revenue
By USInMinutes
Published - May 05, 2023, 12:26 PM ET
Last Updated - Jul 18, 2023, 03:38 PM EDT
Ovid Therapeutics Inc. [OVID] has reported fiscal Q1 loss of $1.30 billion.
On a per-share basis, the DE based company said its diluted earnings are $0.19.
The Pharmaceutical Preparations firm posted revenue of $66.20 million in this period.
Also Read:
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
